methotrexate has been researched along with Placenta Accreta in 75 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (5.33) | 18.7374 |
1990's | 7 (9.33) | 18.2507 |
2000's | 24 (32.00) | 29.6817 |
2010's | 35 (46.67) | 24.3611 |
2020's | 5 (6.67) | 2.80 |
Authors | Studies |
---|---|
Guo, H; Hu, K; Liu, W; Tan, Z; Zhao, R | 1 |
Bertolone, J; Drever, N; Janssens, S; Shawki, M | 1 |
Imai, Y; Matsubara, S; Takahashi, H; Takei, Y | 1 |
Chou, MM; Chuang, SW; Lu, YA; Yuan, JC | 1 |
De Becker, B; Gregoir, C; Hauspy, J; Loquet, P; Vanderheyden, T | 1 |
Endo, M; Kakigano, A; Kimura, T; Matsuzaki, S; Takiuchi, T; Yoshino, K | 1 |
Li, H; Wang, X; Zhang, C; Zuo, C | 1 |
Huang, M; Schlumbrecht, M; Wong, AJ | 1 |
Kreinin, A; Saphier, O; Silberstein, T | 1 |
Matsubara, S; Takahashi, H; Usui, R | 1 |
Kayem, G; Sentilhes, L; Silver, RM | 1 |
Babaei, MR; Farasatinasab, M; Khodaverdi, S; Mohseni, I | 1 |
Gerard Jackson, M; Holls, WH; Stitely, ML | 1 |
Goffinet, F; Kayem, G; Sentilhes, L | 1 |
Arora, R; Bhasin, S; Khan, M; Sachdeva, P | 1 |
Kim, TH; Lee, HH | 1 |
Perez-Delboy, A; Wright, JD | 1 |
Almagor, M; Hovav, Y | 1 |
Carta, A; Carta, G; D'Alfonso, A; Di Luigi, G; Di Stefano, L; Patacchiola, F | 1 |
Cormio, G; Damiani, GR; Farina, A; Landi, S; Loverro, G; Pellegrino, A | 1 |
Agrapidis, D; Antonakopoulos, N; Karras, G; Loutradis, D; Stefanidis, K | 1 |
Hu, W; Lin, J; Lin, K; Qin, J; Xu, K | 1 |
Abuhamad, A; Barton, J; Belfort, MA; Carusi, D; Fox, KA; Huls, C; Lee, P; Secord, AA; Shamshirsaz, AA; Silver, R; Simhan, H; Turan, OM; Wright, J | 1 |
Akashi, Y; Endo, T; Habata, S; Ishioka, S; Matsuura, M; Saito, T; Tamate, M; Tanaka, R | 1 |
Akdemir, N; Cevrioğlu, AS; Gündüz, Y; Ilhan, G; Özden, S | 1 |
Dashti-Khadivaki, S; Farasatinasab, M; Moghaddas, A; Nasiripour, S; Raoofi, Z | 1 |
Dimirov, A; Frundeva, B; Garnizov, T; Masseva, A; Zlatkov, V | 1 |
Bai, H; Cui, R; Lu, J; Zhang, Z | 1 |
Arnadottir, BT; Hardardóttir, H; Marvinsdóttir, B | 1 |
Alvarez Secord, A; Bakelaar, R; Ellestad, SC; Fitpatrick, CB; Havrilesky, LJ; Lee, PS | 1 |
Hays, AM; Roberts, SR; Worley, KC | 1 |
Avillez, T; Casal, E; Hermida, M; Pedroso, S; Pinho, S; Rebordão, M; Santos, A; Sarzedas, S | 1 |
Bian, XM; Fan, GS; Liu, JT; Liu, XY; Yang, JQ; Zhang, C | 1 |
Assimakopoulos, E; Athanatos, D; Bontis, JN; Tarlatzis, BC; Theodoridis, TD; Tzevelekis, P; Zafrakas, M; Zepiridis, L | 1 |
Baba, T; Endo, T; Ezaka, Y; Hayashi, T; Ishioka, S; Matsuura, M; Mizuuchi, M; Nagasawa, K; Saito, T; Shimizu, A | 1 |
Chen, YT; Hu, RM; Li, HQ; Sun, HL; Tan, QY; Xu, LF | 1 |
Arulkumaran, S; Doumouchtsis, SK | 1 |
Hunt, JC | 1 |
Schaap, TP; Scholten, PC; Steins Bisschop, CN; Vogelvang, TE | 1 |
Baradaran, F; Eftekhar, Z; Rahimi-Sharbaf, F; Shojaei, H; Yarandi, F | 1 |
Ayida, G; Crocker, A; Hayes, E | 1 |
Bolte, AC; de Vries, JI; Huirne, JA; Torrenga, B; van Waesberghe, JH | 1 |
Dozier, J; Martin, JN; Tam Tam, KB | 1 |
Akashi, Y; Baba, T; Endo, T; Imai, T; Ishioka, S; Morishita, M; Saito, T; Sugio, A; Tachi, N; Takahashi, M; Tamakawa, M | 1 |
Marth, C; Ramoni, A; Ritter, M; Strobl, EM; Tiechl, J | 1 |
Cole, MD | 1 |
Geary, M; Lalchandani, S; O'Herlihy, C; Sheil, O | 1 |
Blanc, B; Bretelle, F; Courbière, B; Gamerre, M; Porcu, G | 1 |
Crespo, R; Lapresta, M; Madani, B | 1 |
Antonetti-N'Diaye, E; Benoit, G; Bruyère, M; Chauveaud-Lambling, A; de Rudnicki, S; Frydman, R | 1 |
Parker, S; Wong, HS | 1 |
Kahn, JA; Morken, NH | 1 |
Oyelese, Y; Smulian, JC | 1 |
Endo, T; Hayashi, T; Honnma, H; Saito, T | 1 |
Maggiorotto, F; Verma, U | 1 |
Armstrong, M; El-Bialy, G; Kassab, A | 1 |
Abulafia, O; Gorelick, C; Sclafani, S; Sherer, DM; Zigalo, A; Zinn, HL | 1 |
Duvekot, JJ; Timmermans, S; van Hof, AC | 1 |
Heinonen, S; Heiskanen, N; Kainulainen, S; Kröger, J | 1 |
Caritis, SN; Legro, RS; Price, FV | 1 |
Bakri, Y; Sigman, R | 1 |
DuBeshter, B; Jaffe, R; Sherer, DM; Thompson, EA; Woods, JR | 1 |
Caritis, SN; Hill, LM; Legro, RS; Price, FV | 1 |
Buckshee, K; Dadhwal, V | 1 |
Gupta, D; Sinha, R | 1 |
Damarey, I; Durant-Reville, M; Leroy, JL; Robert, Y | 1 |
Ascarelli, A; de Souza, N; Edmonds, KD; Panoskaltsis, TA; Sims, CD | 1 |
Jahshan, A; Riggs, JC; Schiavello, HJ | 1 |
Butt, K; Delisle, MF; Gagnon, A | 1 |
Dudenhausen, JW; Ehrenstein, T; Fuchs, I; Henrich, W; Kjos, S; Schmider, A | 1 |
Ross, GT | 1 |
Arulkumaran, S; Ingemarsson, I; Ng, CS; Ratnam, SS | 1 |
Lipsett, MB; Ross, GT; Van Thiel, DH | 1 |
Grodin, JM; Lipsett, MB; Ross, GT; Van Thiel, DH | 1 |
17 review(s) available for methotrexate and Placenta Accreta
Article | Year |
---|---|
Conservative management of placenta percreta.
Topics: Cesarean Section; Conservative Treatment; Etoposide; Female; Hemorrhage; Humans; Hysterectomy; Methotrexate; Organ Sparing Treatments; Placenta Accreta; Postoperative Complications; Pregnancy; Urinary Bladder; Uterine Artery Embolization | 2018 |
Conservative Management of Placenta Accreta Spectrum.
Topics: Cesarean Section; Conservative Treatment; Enzyme Inhibitors; Female; Humans; Hysterectomy; Hysteroscopy; Ligation; Methotrexate; Organ Sparing Treatments; Placenta Accreta; Placenta, Retained; Pregnancy; Uterine Artery; Uterine Artery Embolization | 2018 |
Management of placenta accreta.
Topics: Abortifacient Agents, Nonsteroidal; Cesarean Section; Combined Modality Therapy; Female; Fertility Preservation; Hemostatic Techniques; Humans; Hysterectomy; Methotrexate; Placenta Accreta; Pregnancy; Prenatal Diagnosis | 2013 |
Conservative management of morbidly adherant placenta - a case report and review of literature.
Topics: Adult; Cesarean Section; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Male; Methotrexate; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Uterine Artery Embolization | 2013 |
Surgical management of placenta accreta: to leave or remove the placenta?
Topics: Abortifacient Agents, Nonsteroidal; Balloon Occlusion; Blood Transfusion; Embolization, Therapeutic; Female; Hemostatics; Humans; Hysterectomy; Methotrexate; Myometrium; Organ Sparing Treatments; Patient Care Planning; Pelvis; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Preoperative Care; Uterus | 2014 |
Conservative management of morbidly adherent placenta: expert review.
Topics: Balloon Occlusion; Blood Loss, Surgical; Enzyme Inhibitors; Female; Humans; Hysterectomy; Hysteroscopy; Ligation; Methotrexate; Myometrium; Organ Sparing Treatments; Placenta Accreta; Placenta, Retained; Postoperative Hemorrhage; Postpartum Hemorrhage; Pregnancy; Prenatal Diagnosis; Time-to-Treatment; Uterine Artery; Uterine Artery Embolization | 2015 |
Management of Abnormal Placenta Implantation with Methotrexate: A Review of Published Data.
Topics: Abortifacient Agents, Nonsteroidal; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy | 2016 |
[CONSERVATIVE MANAGEMENT OF PLACENTA ACCRETE DURING VAGINAL DELIVERY].
Topics: Abortifacient Agents, Nonsteroidal; Delivery, Obstetric; Female; Humans; Hysterectomy; Methotrexate; Placenta; Placenta Accreta; Pregnancy | 2016 |
The morbidly adherent placenta: an overview of management options.
Topics: Blood Loss, Surgical; Blood Transfusion; Catheterization; Cesarean Section; Embolization, Therapeutic; Female; Fertility; Folic Acid Antagonists; Humans; Hysterectomy; Magnetic Resonance Imaging; Methotrexate; Myometrium; Placenta; Placenta Accreta; Placenta Previa; Postoperative Care; Postpartum Hemorrhage; Pregnancy; Prenatal Care; Preoperative Care; Risk Factors; Ultrasonography, Doppler; Ultrasonography, Prenatal; Urinary Bladder Diseases | 2010 |
Invasive placentation and uterus preserving treatment modalities: a systematic review.
Topics: Female; Folic Acid Antagonists; Humans; Hysterectomy; Methotrexate; Placenta Accreta; Pregnancy; Uterine Artery Embolization; Uterus | 2011 |
Conservative management of placenta increta: case report and literature review.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Injections, Intramuscular; Methotrexate; Placenta Accreta; Pregnancy; Stillbirth; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Color | 2011 |
The morbidly adherent placenta: diagnosis and management options.
Topics: Abortifacient Agents, Nonsteroidal; Catheterization; Cesarean Section; Embolization, Therapeutic; Female; Humans; Hysterectomy; Methotrexate; Patient Care Team; Placenta Accreta; Postoperative Care; Postpartum Hemorrhage; Pregnancy | 2011 |
Approaches to reduce urinary tract injury during management of placenta accreta, increta, and percreta: a systematic review.
Topics: Female; Humans; Hysterectomy; Intraoperative Complications; Methotrexate; Placenta Accreta; Pregnancy; Ultrasonography, Prenatal; Urinary Tract | 2012 |
Using methotrexate to treat placenta accreta.
Topics: Abortifacient Agents, Nonsteroidal; Female; Humans; Methotrexate; Obstetric Nursing; Placenta Accreta; Pregnancy | 2002 |
Placenta previa, placenta accreta, and vasa previa.
Topics: Balloon Occlusion; Cesarean Section; Female; Follow-Up Studies; Humans; Hysterectomy; Magnetic Resonance Imaging; Methotrexate; Physical Examination; Placenta Accreta; Placenta Diseases; Placenta Previa; Postpartum Hemorrhage; Pregnancy; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler, Color; Ultrasonography, Prenatal | 2006 |
Conservative management of abnormally invasive placentation.
Topics: Abortifacient Agents, Nonsteroidal; Cesarean Section; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Hysterectomy; Methotrexate; Placenta; Placenta Accreta; Pregnancy; Prenatal Diagnosis; Risk Factors | 2007 |
Management of placenta accreta with oral methotrexate.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Disease-Free Survival; Endosonography; Female; Humans; Klebsiella Infections; Methotrexate; Placenta Accreta; Pregnancy | 1998 |
58 other study(ies) available for methotrexate and Placenta Accreta
Article | Year |
---|---|
Severe toxic effects of low-dose methotrexate treatment for placenta accreta in a patient with methylenetetrahydrofolate reductase mutations.
Topics: Adult; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Mutation; Oral Ulcer; Placenta Accreta; Pregnancy; Severity of Illness Index; Stomatitis | 2020 |
Caesarean scar ectopic pregnancy: Experience from an Australian tertiary centre.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Australia; Cesarean Section; Cicatrix; Cohort Studies; Female; Gestational Age; Humans; Methotrexate; Placenta Accreta; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Retrospective Studies; Tertiary Care Centers | 2020 |
Methotrexate for placenta accreta spectrum disorders: Is it needed?
Topics: Female; Humans; Methotrexate; Placenta Accreta; Pregnancy | 2020 |
Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation.
Topics: Abortion, Induced; Adult; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Fertility Preservation; Humans; Leucovorin; Medical Illustration; Methotrexate; Placenta Accreta; Pregnancy; Pregnancy, Ectopic; Uterine Artery Embolization | 2020 |
The use of methotrexate in conservative treatment of placenta accreta spectrum disorders.
Topics: Conservative Treatment; Embolization, Therapeutic; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy; Retrospective Studies | 2022 |
Retrospective analysis: Conservative treatment of placenta increta with methotrexate.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Conservative Treatment; Female; Humans; Injections; Methotrexate; Placenta Accreta; Pregnancy; Retrospective Studies; Ultrasonography, Interventional; Young Adult | 2018 |
Management of placenta percreta in a Jehovah's Witness patient.
Topics: Adult; Blood Transfusion; Cesarean Section, Repeat; Erythropoietin; Female; Humans; Hysterectomy; Jehovah's Witnesses; Magnetic Resonance Imaging; Methotrexate; Placenta Accreta; Placenta Previa; Pregnancy; Treatment Refusal; Ultrasonography, Prenatal; Uterine Hemorrhage | 2018 |
Methotrexate Treatment for Retained Placental Tissue after Second Trimester Termination of Pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Female; Humans; Methotrexate; Placenta Accreta; Placenta, Retained; Pregnancy; Pregnancy Trimester, Second | 2018 |
Letter to 'Retrospective analysis: Conservative treatment of placenta increta with methotrexate': Some clarifications.
Topics: Abortifacient Agents, Nonsteroidal; Conservative Treatment; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy; Retrospective Studies | 2018 |
In Reply to Letter to the Editor: methotrexate and uterine artery embolization for placenta accreta spectrum disorders: some clarifications.
Topics: Adhesives; Female; Humans; Methotrexate; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Uterine Artery Embolization | 2019 |
Log-linear human chorionic gonadotropin elimination in cases of retained placenta percreta.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin; Female; Humans; Linear Models; Methotrexate; Placenta Accreta; Placenta, Retained; Pregnancy; Retrospective Studies | 2014 |
Conservative management of abnormally invasive placenta after vaginal delivery.
Topics: Embolization, Therapeutic; Female; Humans; Methotrexate; Placenta; Placenta Accreta; Postpartum Hemorrhage; Pregnancy | 2014 |
Risk of choriocarcinoma from postpartum placental remnants staying for extended times in the uterus.
Topics: Abortifacient Agents, Nonsteroidal; Embolization, Therapeutic; Female; Humans; Methotrexate; Placenta; Placenta Accreta; Postpartum Period; Pregnancy | 2014 |
Placenta accreta: conservative approach.
Topics: Embolization, Therapeutic; Female; Fertility Preservation; Humans; Hysterectomy; Methotrexate; Parity; Placenta Accreta; Pregnancy; Uterine Artery; Uterine Myomectomy | 2013 |
Caesarean scar pregnancy complicated by placenta percreta followed by suppurative appendicitis after conservative management with methotrexate.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Appendicitis; Cesarean Section; Cicatrix; Female; Humans; Iatrogenic Disease; Methotrexate; Placenta Accreta; Pregnancy; Pregnancy, Ectopic; Treatment Failure | 2014 |
Diagnosis and management of placenta percreta with bladder involvement.
Topics: Abortifacient Agents; Adult; Cesarean Section; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Methotrexate; Placenta Accreta; Pregnancy; Ultrasonography, Doppler; Urinary Bladder Diseases | 2015 |
Methotrexate management for placenta accreta: a prospective study.
Topics: Adult; China; Chorionic Gonadotropin, beta Subunit, Human; Dilatation and Curettage; Female; Follow-Up Studies; Humans; Methotrexate; Placenta; Placenta Accreta; Pregnancy; Prospective Studies; Ultrasonography; Uterus; Young Adult | 2015 |
Preservation of fertility and subsequent childbirth after methotrexate treatment of placenta percreta: a case report.
Topics: Adult; Chorionic Gonadotropin; Female; Fertility; Humans; Magnetic Resonance Imaging; Methotrexate; Oxytocics; Placenta Accreta; Postpartum Period; Pregnancy; Term Birth | 2015 |
Successful treatment of Placenta Percreta through a combinatorial treatment involving a Bakri Balloon and Methotrexate--a case report.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Blood Loss, Surgical; Combined Modality Therapy; Female; Humans; Methotrexate; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Treatment Outcome; Uterine Balloon Tamponade | 2015 |
The Feasibility of Conservative Management for Morbidly Adherent Placenta Accidentally Encountered after Vaginal Delivery.
Topics: Abortifacient Agents; Adult; Balloon Occlusion; Blood Transfusion; Conservative Treatment; Delivery, Obstetric; Drugs, Chinese Herbal; Feasibility Studies; Female; Humans; Hysterectomy; Methotrexate; Mifepristone; Placenta; Placenta Accreta; Placenta, Retained; Postpartum Hemorrhage; Pregnancy; Retrospective Studies; Uterine Artery Embolization; Vagina | 2017 |
[Case report: seventeen year old primipara with placenta increta, treated with methotrexate].
Topics: Adolescent; Female; Humans; Infant, Newborn; Live Birth; Magnetic Resonance Imaging; Male; Methotrexate; Parity; Placenta Accreta; Pregnancy; Treatment Outcome; Ultrasonography | 2008 |
Medical and surgical treatment of placenta percreta to optimize bladder preservation.
Topics: Adult; Catheterization; Embolization, Therapeutic; Female; Humans; Hysterectomy; Methotrexate; Nucleic Acid Synthesis Inhibitors; Placenta Accreta; Pregnancy; Urinary Bladder Diseases | 2008 |
Conservative management of placenta percreta: experiences in two cases.
Topics: Female; Humans; Hysterectomy; Methotrexate; Nucleic Acid Synthesis Inhibitors; Placenta Accreta; Pregnancy; Urinary Bladder Diseases | 2008 |
Partial placenta increta and methotrexate therapy: three case reports.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Injections, Intramuscular; Methotrexate; Placenta Accreta; Pregnancy; Ultrasonography | 2008 |
[Clinical analysis of 47 cases of placenta accreta in the second and third trimesters].
Topics: Adult; Dilatation and Curettage; Female; Humans; Hysterectomy; Methotrexate; Placenta Accreta; Placenta Previa; Postpartum Hemorrhage; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Risk Factors; Ultrasonography, Prenatal; Uterine Artery Embolization; Uterus; Young Adult | 2008 |
Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Humans; Infant, Newborn; Male; Methotrexate; Placenta Accreta; Placenta, Retained; Placental Lactogen; Postpartum Hemorrhage; Pregnancy; Ultrasonography, Doppler, Color | 2009 |
Successful uterus-preserving surgery for treatment of chemotherapy-resistant placenta increta.
Topics: Adult; Combined Modality Therapy; Drug Resistance; Embolization, Therapeutic; Female; Humans; Infant, Newborn; Methotrexate; Placenta Accreta; Pregnancy; Tomography, X-Ray Computed; Uterus | 2010 |
[Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage].
Topics: Adult; Chemoembolization, Therapeutic; Chorionic Gonadotropin; Female; Follow-Up Studies; Humans; Methotrexate; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Treatment Outcome; Ultrasonography, Doppler, Color; Uterine Artery; Uterus; Vagina; Young Adult | 2010 |
Conservative management of placenta accreta in a multiparous woman.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Anti-Bacterial Agents; Bacteremia; Bacteroidaceae Infections; Chorionic Gonadotropin, beta Subunit, Human; Delivery, Obstetric; Endometritis; Female; Hemoperitoneum; Humans; Hysterectomy; Ileus; Intestinal Obstruction; Methotrexate; Obstetric Labor, Premature; Parity; Peritonitis; Placenta Accreta; Placenta, Retained; Postoperative Complications; Postpartum Hemorrhage; Pregnancy; Prevotella; Uterus | 2010 |
Postpartum monitoring of retained placenta.Two cases of abnormally adherent placenta.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Cesarean Section; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Methotrexate; Placenta; Placenta Accreta; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Pregnancy Outcome; Tissue Adhesions; Treatment Outcome | 2013 |
Committee opinion no. 529: placenta accreta.
Topics: Abortifacient Agents, Nonsteroidal; Cesarean Section; Delivery, Obstetric; Female; Humans; Incidence; Magnetic Resonance Imaging; Methotrexate; Placenta Accreta; Pregnancy; Risk Factors | 2012 |
A myotonic dystrophy 1 patient complicated with placental adherence after miscarriage of one dichorionic diamniotic twin following her tenth in vitro fertilization and embryo transfer.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Abortion, Spontaneous; Adult; Embryo Transfer; Female; Fertilization in Vitro; Humans; Methotrexate; Myotonic Dystrophy; Placenta Accreta; Placenta, Retained; Pregnancy; Pregnancy, Twin; Uterine Hemorrhage | 2012 |
Conservative management of abnormally invasive placenta: four case reports.
Topics: Adult; Cesarean Section; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Methotrexate; Placenta; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Treatment Outcome; Young Adult | 2013 |
Conservative management of placenta accreta and unruptured interstitial cornual pregnancy using methotrexate.
Topics: Adult; Chorionic Gonadotropin, beta Subunit, Human; Female; Gestational Age; Humans; Leucovorin; Methotrexate; Placenta Accreta; Pregnancy; Pregnancy, Ectopic; Treatment Outcome | 2003 |
[Conservative treatment of placenta accreta].
Topics: Abortifacient Agents, Nonsteroidal; Adult; Arteries; Embolization, Therapeutic; Female; France; Humans; Hysterectomy; Incidence; Ligation; Methotrexate; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Retrospective Studies; Stomach; Treatment Outcome; Uterus | 2003 |
Conservative treatment of placenta increta with methotrexate.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Humans; Methotrexate; Placenta Accreta; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Treatment Outcome; Ultrasonography; Uterus | 2005 |
[Management of placenta percreta].
Topics: Adult; Cesarean Section; Cystectomy; Cystoscopy; Female; Humans; Hysterectomy; Magnetic Resonance Imaging; Methotrexate; Placenta Accreta; Pregnancy; Ultrasonography; Urography | 2005 |
Ultrasonographic findings in conservatively treated placenta percreta.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Embolization, Therapeutic; Female; Humans; Methotrexate; Placenta; Placenta Accreta; Pregnancy; Ultrasonography, Prenatal; Uterus | 2005 |
Placenta accreta and methotrexate treatment.
Topics: Adult; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy; Treatment Outcome | 2006 |
Placenta increta: Use of dynamic MRI for diagnosis and evaluation of placental vascularity.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin; Female; Humans; Infant, Newborn; Magnetic Resonance Imaging; Methotrexate; Placenta; Placenta Accreta; Pregnancy | 2007 |
Conservative management of second-trimester cervical ectopic pregnancy with placenta percreta.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Cerclage, Cervical; Cervix Uteri; Female; Humans; Methotrexate; Placenta Accreta; Potassium Chloride; Pregnancy; Pregnancy, Ectopic; Ultrasonography | 2007 |
Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Placenta Accreta; Postpartum Period; Pregnancy | 2007 |
Placenta previa percreta managed conservatively with methotrexate and multiple bilateral uterine artery embolizations.
Topics: Adult; Combined Modality Therapy; Embolization, Therapeutic; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy; Ultrasonography; Uterus | 2007 |
Placenta percreta: methotrexate treatment and MRI findings.
Topics: Abortifacient Agents; Adult; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Myometrium; Placenta Accreta; Pregnancy; Ultrasonography | 2008 |
Successful conservative treatment of placenta percreta.
Topics: Female; Humans; Methotrexate; Placenta Accreta; Placenta Previa; Pregnancy; Treatment Failure; Urinary Bladder Diseases | 1995 |
Effects of methotrexate treatment in placenta percreta with urinary bladder wall invasion.
Topics: Female; Humans; Methotrexate; Placenta Accreta; Pregnancy; Treatment Failure; Urinary Bladder Diseases | 1995 |
Failure of methotrexate treatment for term placenta percreta.
Topics: Adult; Cesarean Section; Female; Humans; Labor, Obstetric; Methotrexate; Placenta Accreta; Pregnancy | 1994 |
Nonsurgical management of placenta percreta: a case report.
Topics: Adult; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy | 1994 |
Medical management of placenta accreta.
Topics: Adult; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy | 1997 |
[Diagnosis of an ectopic pregnancy on a cesarean scar].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Adult; Cesarean Section; Chorionic Gonadotropin; Cicatrix; Female; Humans; Hydatidiform Mole; Methotrexate; Placenta Accreta; Pregnancy; Pregnancy, Ectopic; Trophoblasts; Ultrasonography, Prenatal; Uterine Diseases; Uterine Neoplasms; Uterus | 1999 |
Placenta increta: evaluation of radiological investigations and therapeutic options of conservative management.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Female; Humans; Leucovorin; Magnetic Resonance Imaging; Methotrexate; Placenta Accreta; Pregnancy | 2000 |
Alternative conservative management of placenta accreta. A case report.
Topics: Adult; Balloon Occlusion; Catheterization; Enzyme Inhibitors; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy; Uterine Hemorrhage | 2000 |
Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta.
Topics: Abortifacient Agents, Nonsteroidal; Adult; Catheterization; Cesarean Section; Female; Fetal Membranes, Premature Rupture; Humans; Hysterectomy; Iliac Vein; Methotrexate; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Pregnancy Trimester, Second; Treatment Failure | 2002 |
Antenatal diagnosis of placenta percreta with planned in situ retention and methotrexate therapy in a woman infected with HIV.
Topics: Adult; Cesarean Section; Female; HIV Infections; Humans; Hysterectomy; Magnetic Resonance Imaging; Methotrexate; Placenta Accreta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Prenatal Diagnosis; Ultrasonography, Doppler, Color; Ultrasonography, Prenatal | 2002 |
Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms.
Topics: Abnormalities, Drug-Induced; Antineoplastic Agents; Chlorambucil; Drug Therapy, Combination; Female; Humans; Mechlorethamine; Methotrexate; Placenta Accreta; Pregnancy; Pregnancy Complications; Trophoblastic Neoplasms; Uterine Neoplasms; Vinblastine | 1976 |
Medical treatment of placenta accreta with methotrexate.
Topics: Adult; Female; Humans; Methotrexate; Placenta Accreta; Pregnancy | 1986 |
Pregnancies after chemotherapy of trophoblastic neoplasms.
Topics: Abortion, Spontaneous; Abruptio Placentae; Antineoplastic Agents; Azo Compounds; Dactinomycin; Deafness; DNA; Eczema; Edema; Female; Fetal Death; Follow-Up Studies; Goiter; Hemangioma; Humans; Hyperemesis Gravidarum; Iodine; Mechlorethamine; Methotrexate; Mutation; Placenta Accreta; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications; Strabismus; Tetralogy of Fallot; Trophoblastic Neoplasms; Vinblastine | 1970 |
Partial placenta accreta in pregnancies following chemotherapy for gestational trophoblastic neoplasms.
Topics: Adolescent; Adult; Choriocarcinoma; Curettage; Female; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Placenta Accreta; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Uterus; Vaginal Neoplasms | 1972 |